A Macro View of MicroRNAs

The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease

Cary N. Weiss, Keisuke Ito

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are a class of endogenously encoded ~. 22 nucleotide, noncoding, single-stranded RNAs that contribute to development, body planning, stem cell differentiation, and tissue identity through posttranscriptional regulation and degradation of transcripts. Given their importance, it is predictable that dysregulation of miRNAs, which target a wide variety of transcripts, can result in malignant transformation. In this review, we explore the discovery of miRNAs, their mechanism of action, and the tools that aid in their discovery and study. Strikingly, many of the studies that have expanded our understanding of the contributions of miRNAs to normal physiology and in the development of diseases have come from studies in the hematopoietic system and hematologic malignancies, with some of the earliest identified functions for mammalian miRNAs coming from observations made in leukemias. So, with a special focus on the hematologic system, we will discuss how miRNAs contribute to differentiation of stem cells and how dysregulation of miRNAs contributes to the development of malignancy, by providing examples of specific miRNAs that function as oncogenes or tumor suppressors, as well as of defects in miRNA processing. Finally, we will discuss the promise of miRNA-based therapeutics and challenges for the future study of disease-causing miRNAs.

Original languageEnglish (US)
JournalInternational Review of Cell and Molecular Biology
DOIs
StateAccepted/In press - 2017

Fingerprint

Hematologic Diseases
Hematopoiesis
MicroRNAs
Macros
Hematologic Neoplasms
Stem cells
Stem Cells
Hematopoietic System
Physiology
Oncogenes
Tumors
Cell Differentiation
Neoplasms
Leukemia
Nucleotides
RNA
Tissue
Planning
Degradation

Keywords

  • Cancer
  • Hematopoiesis
  • Leukemia
  • MicroRNA
  • MiRNA
  • MiRNA therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{7b8f54ccd8434c19a7fff01c8b0b4b38,
title = "A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease",
abstract = "MicroRNAs (miRNAs) are a class of endogenously encoded ~. 22 nucleotide, noncoding, single-stranded RNAs that contribute to development, body planning, stem cell differentiation, and tissue identity through posttranscriptional regulation and degradation of transcripts. Given their importance, it is predictable that dysregulation of miRNAs, which target a wide variety of transcripts, can result in malignant transformation. In this review, we explore the discovery of miRNAs, their mechanism of action, and the tools that aid in their discovery and study. Strikingly, many of the studies that have expanded our understanding of the contributions of miRNAs to normal physiology and in the development of diseases have come from studies in the hematopoietic system and hematologic malignancies, with some of the earliest identified functions for mammalian miRNAs coming from observations made in leukemias. So, with a special focus on the hematologic system, we will discuss how miRNAs contribute to differentiation of stem cells and how dysregulation of miRNAs contributes to the development of malignancy, by providing examples of specific miRNAs that function as oncogenes or tumor suppressors, as well as of defects in miRNA processing. Finally, we will discuss the promise of miRNA-based therapeutics and challenges for the future study of disease-causing miRNAs.",
keywords = "Cancer, Hematopoiesis, Leukemia, MicroRNA, MiRNA, MiRNA therapeutics",
author = "Weiss, {Cary N.} and Keisuke Ito",
year = "2017",
doi = "10.1016/bs.ircmb.2017.03.007",
language = "English (US)",
journal = "International Review of Cell and Molecular Biology",
issn = "1937-6448",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - A Macro View of MicroRNAs

T2 - The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease

AU - Weiss, Cary N.

AU - Ito, Keisuke

PY - 2017

Y1 - 2017

N2 - MicroRNAs (miRNAs) are a class of endogenously encoded ~. 22 nucleotide, noncoding, single-stranded RNAs that contribute to development, body planning, stem cell differentiation, and tissue identity through posttranscriptional regulation and degradation of transcripts. Given their importance, it is predictable that dysregulation of miRNAs, which target a wide variety of transcripts, can result in malignant transformation. In this review, we explore the discovery of miRNAs, their mechanism of action, and the tools that aid in their discovery and study. Strikingly, many of the studies that have expanded our understanding of the contributions of miRNAs to normal physiology and in the development of diseases have come from studies in the hematopoietic system and hematologic malignancies, with some of the earliest identified functions for mammalian miRNAs coming from observations made in leukemias. So, with a special focus on the hematologic system, we will discuss how miRNAs contribute to differentiation of stem cells and how dysregulation of miRNAs contributes to the development of malignancy, by providing examples of specific miRNAs that function as oncogenes or tumor suppressors, as well as of defects in miRNA processing. Finally, we will discuss the promise of miRNA-based therapeutics and challenges for the future study of disease-causing miRNAs.

AB - MicroRNAs (miRNAs) are a class of endogenously encoded ~. 22 nucleotide, noncoding, single-stranded RNAs that contribute to development, body planning, stem cell differentiation, and tissue identity through posttranscriptional regulation and degradation of transcripts. Given their importance, it is predictable that dysregulation of miRNAs, which target a wide variety of transcripts, can result in malignant transformation. In this review, we explore the discovery of miRNAs, their mechanism of action, and the tools that aid in their discovery and study. Strikingly, many of the studies that have expanded our understanding of the contributions of miRNAs to normal physiology and in the development of diseases have come from studies in the hematopoietic system and hematologic malignancies, with some of the earliest identified functions for mammalian miRNAs coming from observations made in leukemias. So, with a special focus on the hematologic system, we will discuss how miRNAs contribute to differentiation of stem cells and how dysregulation of miRNAs contributes to the development of malignancy, by providing examples of specific miRNAs that function as oncogenes or tumor suppressors, as well as of defects in miRNA processing. Finally, we will discuss the promise of miRNA-based therapeutics and challenges for the future study of disease-causing miRNAs.

KW - Cancer

KW - Hematopoiesis

KW - Leukemia

KW - MicroRNA

KW - MiRNA

KW - MiRNA therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85018644876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018644876&partnerID=8YFLogxK

U2 - 10.1016/bs.ircmb.2017.03.007

DO - 10.1016/bs.ircmb.2017.03.007

M3 - Article

JO - International Review of Cell and Molecular Biology

JF - International Review of Cell and Molecular Biology

SN - 1937-6448

ER -